Skip to main
SYK
SYK logo

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 43%
Buy 36%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is expected to achieve a notable operating margin improvement of approximately 210 basis points for the years 2024 and 2025, driven by its Operational Excellence initiatives and a robust order book. The company's ongoing focus on expanding into high-growth markets has positively influenced its weighted average market growth rate, indicating strong revenue momentum. Additionally, Stryker projects an increase in EPS from $16.50 in the previous year to $16.69 by 2027, reflecting confidence in sustained financial performance.

Bears say

The negative outlook on Stryker's stock stems from several fundamental challenges, including disruptions caused by recent acquisitions and a slowdown in Mako utilization amid increasing competition, which may adversely affect revenue and operating margins. Furthermore, the company faces risks associated with a declining environment for elective procedures, constrained hospital capital spending, and potential earnings dilution from acquisitions that could hinder overall growth performance. With projections indicating organic revenue growth slowing to 8% or less and expectations of limited margin expansion, Stryker may struggle to meet its long-term earnings growth targets.

Stryker (SYK) has been analyzed by 14 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 36% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 14 analysts, Stryker (SYK) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $432.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $432.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.